MRSN - Mersana Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

MRSN is currently covered by 6 analysts with an average price target of $13.22. This is a potential upside of $6.36 (92.71%) from yesterday's end of day stock price of $6.86.

Mersana Therapeutics's activity chart (see below) currently has 48 price targets and 45 ratings on display. The stock rating distribution of MRSN is 66.67% BUY and 33.33% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 37.78% with an average time for these price targets to be met of 251.67 days.

Highest price target for MRSN is $10, Lowest price target is $5, average price target is $7.33.

Most recent stock forecast was given by ASTHIKA GOONEWARDENE from TRUIST on 16-May-2025. First documented stock forecast 24-Jul-2017.

Currently out of the existing stock ratings of MRSN, 6 are a BUY (66.67%), 3 are a HOLD (33.33%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$10

$3.15 (45.99%)

$9

2 months 19 days ago
(16-May-2025)

0/3 (0%)

$9.66 (2841.18%)

Buy

$5

$-1.85 (-27.01%)

$7

2 months 19 days ago
(16-May-2025)

2/4 (50%)

$4.66 (1370.59%)

573

1 years 5 months 6 days ago
(29-Feb-2024)

1/3 (33.33%)

$10.19 (175.39%)

28

Buy

$7

$0.15 (2.19%)

$2

1 years 5 months 6 days ago
(29-Feb-2024)

3/5 (60%)

$1.56 (28.68%)

191

1 years 5 months 6 days ago
(29-Feb-2024)

0/2 (0%)

$10.19 (175.39%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is MRSN (Mersana Therapeutics) average time for price targets to be met?

On average it took 251.67 days on average for the stock forecasts to be realized with a an average price target met ratio 37.78

Which analyst has the current highest performing score on MRSN (Mersana Therapeutics) with a proven track record?

MICHAEL ULZ

Which analyst has the most public recommendations on MRSN (Mersana Therapeutics)?

Michael Ulz works at MORGAN STANLEY and has 12 price targets and 6 ratings on MRSN

Which analyst is the currently most bullish on MRSN (Mersana Therapeutics)?

Michael Ulz with highest potential upside - $25.74

Which analyst is the currently most reserved on MRSN (Mersana Therapeutics)?

Ashik Kurian with lowest potential downside - -$5.85

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?